|
[1]
|
Park, J.Y., Forman, D., Waskito, L.A., Yamaoka, Y. and Crabtree, J.E. (2018) Epidemiology of Helicobacter pylori and CagA-Positive Infections and Global Variations in Gastric Cancer. Toxins, 10, Article No. 163. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Piazuelo, M.B., Epplein, M. and Correa, P. (2010) Gastric Cancer: An Infectious Disease. Infectious Disease Clinics of North America, 24, 853-869. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Joshi, S.S. and Badgwell, B.D. (2021) Current Treatment and Recent Progress in Gastric Cancer. CA: A Cancer Journal for Clinicians, 71, 264-279. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Schistosomes (1994) Liver Flukes and Helicobacter pylori. IARC Monographs on the Identification of Carcinogenic Hazards to Humans, Vol. 61, 1-241.
|
|
[5]
|
Helicobacter and Cancer Collaborative Group (2001) Gastric Cancer and Helicobacter pylori: A Combined Analysis of 12 Case Control Studies Nested within Prospective Cohorts. Gut, 49, 347-353. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Kamangar, F., Dawsey, S.M., Blaser, M.J., Perez-Perez, G.I., Pietinen, P., Newschaffer, C.J., et al. (2006) Opposing Risks of Gastric Cardia and Noncardia Gastric Adenocarcinomas Associated with Helicobacter pylori Seropositivity. JNCI: Journal of the National Cancer Institute, 98, 1445-1452. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., et al. (2001) Helicobacter pylori Infection and the Development of Gastric Cancer. New England Journal of Medicine, 345, 784-789. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
El-Omar, E.M., Carrington, M., Chow, W., McColl, K.E.L., Bream, J.H., Young, H.A., et al. (2000) Interleukin-1 Polymorphisms Associated with Increased Risk of Gastric Cancer. Nature, 404, 398-402. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
El-Omar, E.M., Carrington, M., Chow, W., McColl, K.E.L., Bream, J.H., Young, H.A., et al. (2001) Correction: The Role of Interleukin-1 Polymorphisms in the Pathogenesis of Gastric Cancer. Nature, 412, 99. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Crabtree, J.E., Taylor, J.D., Heatley, R.V., Shallcross, T.M., Rathbone, B.J., Wyatt, J.I., et al. (1991) Mucosal IgA Recognition of Helicobacter pylori 120 Kda Protein, Peptic Ulceration, and Gastric Pathology. The Lancet, 338, 332-335. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Ohnishi, N., Yuasa, H., Tanaka, S., Sawa, H., Miura, M., Matsui, A., et al. (2008) Transgenic Expression of Helicobacter pylori CagA Induces Gastrointestinal and Hematopoietic Neoplasms in Mouse. Proceedings of the National Academy of Sciences, 105, 1003-1008. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Nishikawa, H. and Hatakeyama, M. (2017) Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA Oncoprotein. Toxins, 9, Article No. 136. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Chen, D., Li, C., Zhao, Y., Zhou, J., Wang, Q. and Xie, Y. (2021) Bioinformatics Analysis for the Identification of Differentially Expressed Genes and Related Signaling Pathways in H. pylori-CagA Transfected Gastric Cancer Cells. PeerJ, 9, e11203. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Xu, W., Xu, L. and Xu, C. (2022) Relationship between Helicobacter pylori Infection and Gastrointestinal Microecology. Frontiers in Cellular and Infection Microbiology, 12, Article ID: 938608. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Zavros, Y. and Merchant, J.L. (2022) The Immune Microenvironment in Gastric Adenocarcinoma. Nature Reviews Gastroenterology & Hepatology, 19, 451-467. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Li, X., Sun, X., Kan, C., Chen, B., Qu, N., Hou, N., et al. (2022) COL1A1: A Novel Oncogenic Gene and Therapeutic Target in Malignancies. Pathology—Research and Practice, 236, Article ID: 154013. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Van Doren, S.R. (2015) Matrix Metalloproteinase Interactions with Collagen and Elastin. Matrix Biology, 44, 224-231. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Guo, Y., Lu, G., Mao, H., Zhou, S., Tong, X., Wu, J., et al. (2020) miR-133b Suppresses Invasion and Migration of Gastric Cancer Cells via the COL1A1/TGF-β Axis. OncoTargets and Therapy, 13, 7985-7995. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Wang, Q. and Yu, J. (2018) miR-129-5p Suppresses Gastric Cancer Cell Invasion and Proliferation by Inhibiting COL1A1. Biochemistry and Cell Biology, 96, 19-25. [Google Scholar] [CrossRef] [PubMed]
|